Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 926 to 950 of about 5901

Previous 25

Website Changes

04/25/2020

A Phase II Randomized, Multicenter, Open-Label Trial of Continuing Adjuvant Temozolomide Beyond Six Cycles in Patients With Glioblastoma (GEINO 14-01)

04/24/2020

Immunotherapies combine for triple threat against deadly brain cancer

04/23/2020

Reinforcement Learning for Optimal Scheduling of Glioblastoma Treatment With Temozolomide

04/23/2020

Surveys! We need your participation!

04/18/2020

NW Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder Meeting

04/17/2020

Lessons Learned in Using Laser Interstitial Thermal Therapy (LITT) for Treatment of Brain Tumors: A Case Series of 238 Patients From A Single Institution

04/10/2020

Musella Foundation Webinar Series: This Sunday 4/12/2020

04/10/2020

Prophylactic Anticonvulsant Therapy in High-Grade Glioma: A Systematic Review and Meta-Analysis of Longitudinal Studies

04/08/2020

Study Shows Possible Alternative Treatment for High-Grade Glioma Tumors in Infants

04/06/2020

Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.

04/05/2020

Brain Tumor Patients and the COVID-19 Crisis! Live Webinar tonight (4/5/2020) 7pm Eastern Time

04/05/2020

Brain Tumor Patients and the COVID-19 Crisis

04/05/2020

Musella Foundation Copayment Assistance Program now open to New (and Renewal) Patients!

04/03/2020

MATEON THERAPEUTICS TEAM PUBLISHES A NEW PEER-REVIEWED ONCOLOGY ARTICLE ON THE POSITIVE CLINICAL STUDY RESULTS FOR OT-101 AGAINST RECALCITRANT RESISTANT ANAPLASTIC ASTROCYTOMA – A RARE FORM OF MALIGNANT BRAIN TUMOR

04/03/2020

Study: Niacin may help immune system battle a deadly brain tumor

04/02/2020

Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.

04/02/2020

Phase I/II Clinical Study of ONC201 Begins in Japan

03/31/2020

UF brain tumor researcher embarks on first-in-human clinical trial of novel immunotherapy vaccine

03/30/2020

Musella Foundation Webinar Series

03/30/2020

03/28/2020

Stimulus plan: Changes to charitable contributions!

03/28/2020

12 medical centers form brain tumor research collaborative

03/20/2020

Young girl with incurable tumour may not receive lifeline treatment in New York

03/20/2020

German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany

03/19/2020

5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery

Our privacy / cookie policy has changed.
Click HERE to read it!